About Aronora
Aronora is engaged in the commercial development of proprietary antithrombotic therapeutics. Our innovative drugs can stop the growth of blood clots without the detrimental bleeding side effects that characterize all antithrombotic drugs currently on the market. Our products are intended to be used in difficult-to-treat, severe, rapidly progressing, or catastrophic thrombotic blood clotting diseases, including suspected or verified stroke, heart attack, pulmonary embolism, or severe infections. Building on the company’s ground-breaking approaches to superior drug safety, Aronora’s product candidates have the potential to become first-in-class medical emergency therapeutics to treat acute thrombotic diseases.
Partnering Opportunities
Aronora is committed to building a portfolio of safe antithrombotic drugs for a variety of clinical indications. To reach our objective, we have implemented a well-defined strategy that guides the identification of potential partnerships to support our product pipeline. We will consider private investor interest, strategic partnerships, and out-licensing opportunities that are consistent with our business strategy. Aronora’s product development programs have been awarded several small business innovation research grants from the National Institutes of Health.
Careers
Aronora’s innovative approach to cardiovascular drug discovery and development provide a unique opportunity for creative individuals to make a significant impact on human health. We are committed to expanding our team with qualified, talented, and passionate individuals driven to creating exceptional products and building an exceptional company. At present, we are not seeking to fill positions. Please check back for potential openings in the near future.